Dr. Victor Blanchette is Medical Director of the Pediatric Thrombosis and Hemostasis Program in the Division of Haematology/Oncology at the Hospital for Sick Children in Toronto, and Professor of Pediatrics at the University of Toronto, Canada. He is a Senior Associate Scientist in the Research Institute of the Hospital for Sick Children, and a Clinician Investigator in the Hospital’s Department of Paediatrics.
After completing his medical training at the University of Cambridge and St Bartholomew's Hospital in the United Kingdom, Dr Blanchette pursued subspecialty training in pediatrics at Johns Hopkins Hospital in Baltimore, Maryland, USA followed by fellowship training in pediatric hematology/oncology at McMaster University Medical Centre in Hamilton, Ontario, Canada.
Dr Blanchette's research interests are in the area of the congenital and acquired bleeding disorders of children. He is Director of the Pediatric Comprehensive Care Hemophilia Program at the Hospital for Sick Children, and Chairman of the Factor Prophylaxis Subcommittee of the Association of Hemophilia Clinic Directors of Canada (AHCDC). He is also Chair of the Canadian Pediatric Thrombosis and Hemostasis Network (CPTHN) and of the International Prophylaxis Study Group (IPSG). Dr Blanchette is an elected fellow of the Royal College of Physicians and Surgeons of the United Kingdom.
- Blanchette VS, Manco-Johnson M, Santagostino E, Ljung R: Optimizing factor prophylaxis for the haemophilia population: where do we stand? Haemophilia 2004:10 Suppl 4: pp 97-104
- Manco-Johnson MJ, Pettersson H, Petrini P, Babyn PS, Bergstrom B-M, Bradley C-S, Doria AS, Feldman BM, Funk S, Hilliard P, Kilcoyne R, Lundin B, Nuss R, Rivard G, Schoenmakers MAGC, Van Den Berg M, Wiedel J, Zourikian N, Blanchette VS: Physical therapy and imaging outcome measures in a haemophiliia population treated with factor prophylaxis: current status and future directions.
- van den Berg HM, Dunn A, Fischer K, Blanchette VS: Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy. Haemophilia 2006: 12 Suppl 3: pp 159-68
- Blanchette VS: Prophylaxis in the haemophilia population. Haemophilia 2010:16(Suppl 5):pp 181-188, July 2010.